Search
for

    Learn

    5 / 20 results

      learn Clascoterone

      a novel topical treatment that inhibits DHT on androgen receptors

      learn Fluridil

      a topical anti-androgen with less systemic involvement
      [object Object]

      learn Spironolactone

      powerful topical and oral anti-androgen used mostly by women

      learn RU58841

      a potent but unapproved and potentially problematic topical anti-androgen

    Research

    5 / 1000+ results

    Community Join

    5 / 1000+ results

      community cb-03-01 research chem (winlevi/clascoterone cream)

      in Technology  3 upvotes 1 year ago
      The user is considering using CB or clascoterone for hair loss, potentially as an alternative to RU. They're also contemplating asking a dermatologist for topical clascoterone cream to apply to their temple.

      community Androgenetic alopecia is a skin disease: DHT-mediated skin disorders

      in Research/Science  62 upvotes 1 year ago
      Dihydrotestosterone (DHT) impacts various skin conditions, including Androgenetic alopecia and seborrheic dermatitis, by causing overactivity in sebaceous glands. Topical medications Tacrolimus and Clobetasol can reduce these inflammatory conditions, and treatments like RU58841, Minoxidil, and Finasteride may also be beneficial.
      [object Object]

      community The ultimate Regimen for density and thick ess

      in Treatment  10 upvotes 3 months ago
      The regimen for hair loss includes topical finasteride, clascoterone, tretinoin, minoxidil, oral saw palmetto, beta-sitosterol, vitamin D, microneedling, and anti-fungal shampoo. Expected benefits are increased hair growth and density, with considerations for potential skin irritation and interactions between treatments.

      community Clascoterone (Winlevi) now approved in Canada

      in Product  13 upvotes 1 year ago
      The conversation is about the approval of Clascoterone (Winlevi) in Canada for hair loss treatment. One user expressed skepticism about its effectiveness due to low concentration.

      community Breezula phase 3 results said to be released next month

      in Product  25 upvotes 3 weeks ago
      Breezula's phase 3 results are expected soon, with discussions on the effectiveness of androgen receptor antagonists like spironolactone and the potential of GT20029. Users express skepticism about new treatments and discuss the complexities of male pattern baldness, often relying on finasteride despite its side effects.